These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2144686)

  • 1. Classification of prostanoid receptors.
    Gardiner PJ
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():110-8. PubMed ID: 2144686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress.
    Woodward DF; Jones RL; Narumiya S
    Pharmacol Rev; 2011 Sep; 63(3):471-538. PubMed ID: 21752876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostanoid receptors and the urogenital tract.
    Breyer MD; Hébert RL; Breyer RM
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1343-53. PubMed ID: 14758774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
    Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
    Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies.
    Woodward DF; Lawrence RA; Fairbairn CE; Shan T; Williams LS
    J Lipid Mediat; 1993; 6(1-3):545-53. PubMed ID: 8358015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
    Coleman RA; Smith WL; Narumiya S
    Pharmacol Rev; 1994 Jun; 46(2):205-29. PubMed ID: 7938166
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature.
    Coleman RA; Eglen RM; Jones RL; Narumiya S; Shimizu T; Smith WL; Dahlén SE; Drazen JM; Gardiner PJ; Jackson WT
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():283-5. PubMed ID: 7732854
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure and function of prostanoid receptors.
    Narumiya S; Hirata N; Namba T; Hayashi Y; Ushikubi F; Sugimoto Y; Negishi M; Ichikawa A
    J Lipid Mediat; 1993; 6(1-3):155-61. PubMed ID: 8395239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bimatoprost-induced calcium signaling in human T-cells does not involve prostanoid FP or TP receptors.
    Chen J; Lu RT; Lai R; Dinh T; Paul D; Venadas S; Wheeler LA
    Curr Eye Res; 2009 Mar; 34(3):184-95. PubMed ID: 19274525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current topics in the regulation of prostanoids--3. Prostanoid synthases and prostanoid receptors].
    Ohara M; Sawa T
    Masui; 1999 Jan; 48(1):42-7. PubMed ID: 10036888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostanoid receptor subtypes: new targets for OAB drugs?
    Andersson KE
    J Urol; 2009 Nov; 182(5):2099-100. PubMed ID: 19758658
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostanoid-induced blood-aqueous barrier breakdown in rabbits involves the EP2 receptor subtype.
    Protzman CE; Woodward DF
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2463-6. PubMed ID: 2173691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.
    Hirano Y; Shichijo M; Deguchi M; Nagira M; Suzuki N; Nishitani Y; Hattori M; Arimura A
    Eur J Pharmacol; 2007 Mar; 560(1):81-8. PubMed ID: 17307163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle.
    Krauss AH; Wiederholt M; Sturm A; Woodward DF
    Exp Eye Res; 1997 Mar; 64(3):447-53. PubMed ID: 9196397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal effects of isoprostanes: evidence for the involvement of prostanoid EP and TP receptors.
    Elmhurst JL; Betti PA; Rangachari PK
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1198-205. PubMed ID: 9316826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potent and selective DP1 receptor antagonists in the azaindole series.
    Leblanc Y; Roy P; Dufresne C; Lachance N; Wang Z; O'Neill G; Greig G; Denis D; Mathieu MC; Slipetz D; Sawyer N; Tsou N
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2125-8. PubMed ID: 19307115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future directions in anxiolytic pharmacotherapy.
    Kunovac JL; Stahl SM
    Psychiatr Clin North Am; 1995 Dec; 18(4):895-909. PubMed ID: 8748388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new chemical leads for prostaglandin D2 receptor antagonists.
    Torisu K; Kobayashi K; Iwahashi M; Egashira H; Nakai Y; Okada Y; Nanbu F; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4557-62. PubMed ID: 15357992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galanin receptor subtypes.
    Wang S; Gustafson EL
    Drug News Perspect; 1998 Oct; 11(8):458-68. PubMed ID: 15616674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.